News | March 14, 2024
Zydus launches generic version of Olaparib ‘IBYRA’ in India
The drug will target specific genetic mutations prevalent in certain types of cancers
The drug will target specific genetic mutations prevalent in certain types of cancers
It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation
The 200 bedded hospital owned & operated by Alexis
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Express Scripts to add Zepbound to National Preferred Formulary
The product will be manufactured at Lupin’s Nagpur facility in India
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Subscribe To Our Newsletter & Stay Updated
